GARY A LYONS Insider Trading $VICL Brickell Biotech, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GARY A LYONS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GARY A LYONS. GARY A LYONS is in Brickell Biotech, Inc. ($VICL) and Director in VICAL INC ($VICL) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CYTORI THERAPEUTICS, INC. ($XMP) and Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and Director in Novus Therapeutics, Inc. ($TKAI) and Director in Retrophin, Inc. ($RTRX).

GARY A LYONS in Brickell Biotech, Inc.

Trading Symbol: VICL
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GARY A LYONS: Director
Holdings: 24,729 shares
Current Value: $52,673
Latest Transaction: Sep 17 2020
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of GARY A LYONS in Brickell Biotech, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, IBPI, VICL, ELDN, KBIO, NBIX, PSTV, RIGL, RTRX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 17 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseA0.8060,00048,00060,000
Sep 17 2020VICLBrickell Biotech, ...LYONS GARY ADirectorGrantA0.8111,9349,66724,72912.8 K to 24.7 K (+93.27 %)
Sep 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.0069200
Sep 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF0.948,6318,11312,79521.4 K to 12.8 K (-40.28 %)
Sep 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF0.9434632521,42621.8 K to 21.4 K (-1.59 %)
Sep 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.00692021,77221.1 K to 21.8 K (+3.28 %)
Aug 04 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.006920692
Aug 04 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF0.9234631821,08021.4 K to 21.1 K (-1.61 %)
Aug 04 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.00692021,42620.7 K to 21.4 K (+3.34 %)
Jul 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.0069101,384
Jul 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF1.0034634620,73421.1 K to 20.7 K (-1.64 %)
Jul 02 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.00691021,08020.4 K to 21.1 K (+3.39 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseA1.124,3334,8534,333
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.006920692
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.006920692
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.006910691
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.006920692
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorOption ExerciseM0.003,49103,491
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorGrantA0.0017,261020,3893.1 K to 20.4 K (+551.82 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF1.163464013,1283.5 K to 3.1 K (-9.96 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.0069203,4742.8 K to 3.5 K (+24.87 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF1.203464152,7823.1 K to 2.8 K (-11.06 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.0069203,1282.4 K to 3.1 K (+28.41 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF1.193464122,4362.8 K to 2.4 K (-12.44 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.0069102,7822.1 K to 2.8 K (+33.05 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF2.933461,0142,0912.4 K to 2.1 K (-14.20 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.0069202,4371.7 K to 2.4 K (+39.66 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorPayment of ExerciseF1.161,7462,0251,7453.5 K to 1.7 K (-50.01 %)
Jun 05 2020VICLBrickell Biotech, ...LYONS GARY ADirectorBuyM0.003,49103,4910 to 3.5 K
Feb 19 2020VICLBrickell Biotech, ...LYONS GARY AOption ExerciseA1.168,3339,6668,333
Feb 19 2020VICLBrickell Biotech, ...LYONS GARY AOption ExerciseA1.162,1672,5142,167
May 24 2018VICLVICAL INCLYONS GARY ADirectorOption ExerciseA1.676,50010,8556,500
May 30 2017VICLVICAL INCLYONS GARY ADirectorOption ExerciseA2.366,50015,3406,500
Dec 07 2016VICLVICAL INCLYONS GARY ADirectorSellS2.307,07816,2487,82814.9 K to 7.8 K (-47.48 %)
Jun 06 2016VICLVICAL INCLYONS GARY ADirectorBuyP4.397,07831,08914,9067.8 K to 14.9 K (+90.42 %)
May 24 2016VICLVICAL INCLYONS GARY ADirectorOption ExerciseA0.3665,00023,46565,000
May 26 2015VICLVICAL INCLYONS GARY ADirectorOption ExerciseA0.8950,00044,50050,000
May 26 2015VICLVICAL INCLYONS GARY ADirectorGrantA0.017,5007578,28170.8 K to 78.3 K (+10.60 %)

Page:   1